Bayesian Indirect Comparison and Cost-Effectiveness of Sacituzumab Govitecan Versus Sacituzumab Tirumotecan in Metastatic Triple-Negative Breast Cancer

Value in Health 2026

View at publisher
Authors: Yamin Shu, Ying Tang, Yiling Ding, Wenting Zhang, Qilin Zhang
DOI: 10.1016/j.jval.2026.02.004
Cited by: 1
References: 38

Fields of Study & Subjects

HER2/EGFR in Cancer Research Cancer Immunotherapy and Biomarkers Statistical Methods in Clinical Trials

Publication details

Journal / source
Value in Health
Publisher
Elsevier BV
Volume
29
Issue
8
Pages
1385–1394
Publication date
24 February 2026
Language
EN